This brand name is authorized in Austria, Australia, Brazil, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, Hong Kong, Croatia, Ireland, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa
The drug IMIGRAN contains one active pharmaceutical ingredient (API):
1
Sumatriptan
UNII J8BDZ68989 - SUMATRIPTAN SUCCINATE
|
Sumatriptan has been demonstrated to be a specific and selective 5-Hydroxytryptamine1 (5HT1D) receptor agonist with no effect on other 5HT receptor (5-HT2 - 5-HT7) subtypes. The vascular 5-HT1D receptor is found predominantly in cranial blood vessels and mediates vasoconstriction. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
IMIGRAN Tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
IMIGRAN Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
IMIGRAN Nasal spray, solution | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
N02CC01 | Sumatriptan | N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CC Selective serotonin (5HT1) agonists |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 10694W, 1849H, 8144P, 8341B, 8885P |
Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 510603801111310, 510603802116316 |
Country: DE | Bundesinstitut für Arzneimittel und Medizinprodukte | Identifier(s): 00686256, 00686279, 00686322, 00686411, 00839211, 07275042, 07320593 |
Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): H4150413, H4160413 |
Country: EE | Ravimiamet | Identifier(s): 1024771, 1139880, 1139891, 1139903, 1139914, 1139936, 1139947, 1680577 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 59973, 61629, 61630, 66406 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 005958, 013597, 013608, 018782, 018787, 018793, 018798, 018831, 018920, 093252, 093260, 198747, 411918, 415422 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 139154, 139158, 142500, 142502, 142506, 142510, 142513, 161901, 161903, 161905, 161910, 161912, 161914, 161916, 161918, 175622, 18519, 18546, 196146, 198745, 198747, 27747, 34890, 34891, 368034, 368036, 368038, 374175, 376553, 377200, 377202, 381401, 392150, 394069, 43703, 47897, 94846, 94849 |
Country: HK | Department of Health Drug Office | Identifier(s): 39285 |
Country: HR | Agencija za lijekove i medicinske proizvode | Identifier(s): HR-H-584958851 |
Country: IE | Health Products Regulatory Authority | Identifier(s): 29002, 29059, 29118, 29136, 29220, 29253, 30633, 30644, 32060, 32061, 32062, 36555 |
Country: IT | Agenzia del Farmaco | Identifier(s): 027975059, 027975061, 027975073 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 2160003F1022, 2160402G1026 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1003053, 1003055, 1003058, 1004663, 1004664, 1074067, 1074068, 1074069, 1074070 |
Country: MT | Medicines Authority | Identifier(s): MA192/04001 |
Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 096M92, 568M95 |
Country: NL | Z-Index G-Standaard | Identifier(s): 13783149, 13784129 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 38210, 45845, 62359, 67679, 79480, 79499 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 5569 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100030311, 100030328, 100078000, 100101229, 100164690, 100164709 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W64946001, W64946002, W64946003, W64946004, W64946005, W64948001, W64948002, W64948003, W64948004, W64948005 |
Country: SG | Health Sciences Authority | Identifier(s): 06744P, 08419P |
Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 14263011, 24833021 |
Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699522092895, 8699522092901, 8699522092918, 8699522099276, 8699522952922, 8699522952939 |
Country: ZA | Health Products Regulatory Authority | Identifier(s): 28/7.3/0726, 31/7.3/0197, Z/7.3/11, Z/7.3/12 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.